BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 616551)

  • 1. Immunological response of subacute sclerosing panencephalitis patients to measles virus.
    Madden DL; Fuccillo DA; Castellano G; Traub R; Krezlewicz A; Sever JL
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):509-20. PubMed ID: 616551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated cytotoxicity against measles virus in SSPE. I. Enhancement by antibody.
    Kreth HW; Meulen V
    J Immunol; 1977 Jan; 118(1):291-5. PubMed ID: 830752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.
    Kreth WH; Käckell MY; ter Meulen V
    J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interpretation of the results of identification of measles virus antibodies in the serum and cerebrospinal fluid from patients with suspected subacute sclerosing panencephalitis (SSPE)].
    Gut W; Panfist A
    Med Dosw Mikrobiol; 1991; 43(3-4):145-52. PubMed ID: 1823377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
    Perrin LH; Tishon A; Oldstone MB
    J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis.
    Dhib-Jalbut S; Jacobson S; McFarlin DE; McFarland HF
    Ann Neurol; 1989 Mar; 25(3):272-80. PubMed ID: 2786368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines].
    Kuwajima S
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):5-14. PubMed ID: 3699682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells.
    Kreth HW; Wiegand G
    J Immunol; 1977 Jan; 118(1):296-301. PubMed ID: 830753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus.
    Wechsler SL; Weiner HL; Fields BN
    J Immunol; 1979 Aug; 123(2):884-9. PubMed ID: 458157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological and immunological studies in experimental SSPE.
    Johnson KP; Byington DP; Gaddis L
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):495-507. PubMed ID: 616550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute sclerosing panencephalitis: detection of measles antibody in serum and cerebrospinal fluid by enzyme-linked immunosorbent assay, complement fixation and hemagglutination inhibition.
    Ferrante P; Achilli G; Gerna G; Bergamini F
    Microbiologica; 1987 Jan; 10(1):111-8. PubMed ID: 3574144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute sclerosing panencephalitis (SSPE).
    Lapointe N; Geoffroy G; McLaughlin B; Mongeau JG
    Birth Defects Orig Artic Ser; 1975; 11(1):239-43. PubMed ID: 1096980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis.
    Steele RW; Fuccillo DA; Hensen SA; Vincent MM; Bellanti JA
    J Pediatr; 1976 Jan; 88(1):56-62. PubMed ID: 812971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of measles virus antibodies in SSPE.
    Jankowski MA; Gut W; Kańtoch M
    Acta Virol; 1982 Dec; 26(6):481-7. PubMed ID: 6132542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles-specific IgG in CSF and serum from patients with subacute sclerosing panencephalitis.
    Mehta PD; Patrick BA; Thormar H
    Immunology; 1982 Jun; 46(2):423-8. PubMed ID: 7084997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated cytotoxicity after measles virus infection.
    Kibler R; Meulen VT
    J Immunol; 1975 Jan; 114(1 Pt 1):93-8. PubMed ID: 803529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
    Sheremata W; Sazant A; Watters G
    Can Med Assoc J; 1978 Mar; 118(5):509-13. PubMed ID: 343902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow measles encephalitis or subacute sclerosing panencephalitis.
    Bosnjak I; Barac V
    Neurol Croat; 1991; 40(3):187-92. PubMed ID: 1932443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the level of humoral response for measles virus in patients with subacute sclerotic panencephalitis during 1984-1989].
    Gut W
    Med Dosw Mikrobiol; 1992; 44(3-4):173-85. PubMed ID: 1305922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.